PharmaCyte Biotech, Inc. Quarterly Earnings Per Share, Diluted in USD/shares from Q2 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Summary
PharmaCyte Biotech, Inc. quarterly/annual Earnings Per Share, Diluted history and growth rate from Q2 2021 to Q2 2024.
  • PharmaCyte Biotech, Inc. Earnings Per Share, Diluted for the quarter ending July 31, 2024 was 1.9 USD/shares.
  • PharmaCyte Biotech, Inc. Earnings Per Share, Diluted for the twelve months ending July 31, 2024 was 0.64 USD/shares.
  • PharmaCyte Biotech, Inc. annual Earnings Per Share, Diluted for 2023 was -1.8 USD/shares, a 718% decline from 2022.
  • PharmaCyte Biotech, Inc. annual Earnings Per Share, Diluted for 2022 was -0.22 USD/shares, a 18.5% increase from 2021.
  • PharmaCyte Biotech, Inc. annual Earnings Per Share, Diluted for 2021 was -0.27 USD/shares, a 89% increase from 2020.
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Quarterly (USD/shares)
Earnings Per Share, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $0.64 $1.90 +$2.44 May 1, 2024 Jul 31, 2024 10-Q 2024-09-17
Q1 2024 -$2 $0 $0 -1650% Feb 1, 2024 Apr 30, 2024 10-K 2024-08-13
Q4 2023 -$1 -$1 -$1 -1525% Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-18
Q3 2023 -$1 $0 $0 -189% Aug 1, 2023 Oct 31, 2023 10-Q 2023-12-15
Q2 2023 -$1 -$1 $0 -671% May 1, 2023 Jul 31, 2023 10-Q 2024-09-17
Q1 2023 $0 $0 $0 -104% Feb 1, 2023 Apr 30, 2023 10-K 2024-08-13
Q4 2022 $0.27 $0 $0 0% Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-18
Q3 2022 $0.27 $0 $0 -50% Aug 1, 2022 Oct 31, 2022 10-Q 2023-12-15
Q2 2022 $0.30 $0 +$0.57 +89.1% May 1, 2022 Jul 31, 2022 10-Q 2023-09-18
Q1 2022 $0 $0.47 Feb 1, 2022 Apr 30, 2022 10-K 2023-07-31
Q4 2021 $0 Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-16
Q3 2021 $0 Aug 1, 2021 Oct 31, 2021 10-Q 2022-12-14
Q2 2021 -$1 May 1, 2021 Jul 31, 2021 10-Q 2022-09-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.